Oracle (ORCL) Stock Forecast & Price Target

Q: What analysts cover Oracle?

Oracle has been rated by research analysts at Argus , Barclays , BMO Capital Markets , Cantor Fitzgerald , Citigroup , Citizens Jmp , CLSA , DA Davidson , Freedom Broker , Guggenheim , Jefferies Financial Group , KeyCorp , Morgan Stanley , Oppenheimer , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Stephens , Stifel Nicolaus , TD Cowen , UBS Group , and Weiss Ratings in the past 90 days.

$144.44 -4.76 (-3.19%)

Closing price 03:59 PM Eastern

Extended Trading

$144.50 +0.06 (+0.04%)

As of 07:00 PM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 41 Analyst Ratings

Sell
1

Hold
8

Buy
32

Based on 41 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 1 has given a sell rating, 8 have given a hold rating, 30 have given a buy rating, and 2 have given a strong buy rating for ORCL.

Consensus Price Target

$252.58
74.87% Upside

According to the 41 analysts' twelve-month price targets for Oracle, the average price target is $252.58. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $145.00. The average price target represents a forecasted upside of 74.87% from the current price of $144.44.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 9/23/25 to 9/23/26	1 Month Ago 8/24/25 to 8/24/26	3 Months Ago 6/25/25 to 6/25/26	1 Year Ago 9/23/24 to 9/23/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	30 Buy rating(s)	28 Buy rating(s)	28 Buy rating(s)	24 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	7 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$252.58	$263.97	$268.27	$303.52
Forecasted Upside	74.87% Upside	85.32% Upside	75.55% Upside	-3.61% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Technology Companies	Broader Market
Consensus Rating Score	2.80	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	69.38% Upside	1,266.96% Upside	17.93% Upside
News Sentiment Rating	Neutral News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/14/2026	Freedom Broker Not Rated	Egor Tolmachev Not Rated	Lower Target	Buy	$210.00 ➝ $205.00	+41.88%
9/14/2026	Argus 3 of 5 stars	Joseph Bonner Not Rated	Reiterated Rating	Buy	$225.00	+49.87%
9/11/2026	UBS Group 4 of 5 stars	Karl Keirstead 3 of 5 stars	Boost Target	Buy	$245.00 ➝ $250.00	+59.94%
9/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$220.00 ➝ $200.00	+30.57%
9/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$250.00 ➝ $252.00	+64.52%
9/11/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$285.00	+86.07%
9/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
9/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$190.00 ➝ $165.00	+5.53%
9/11/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+43.90%
9/11/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$175.00	+14.25%
Get the Latest News and Ratings for ORCL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oracle and its competitors with MarketBeat's FREE daily newsletter.
9/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$220.00 ➝ $195.00	+27.31%
9/11/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$284.00	+85.41%
9/9/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$240.00	+48.39%
9/9/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Outperform	$241.00 ➝ $215.00	+33.19%
9/9/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$285.00	+75.36%
9/8/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+152.13%
9/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform
9/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$207.00 ➝ $210.00	+35.92%
9/2/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark L. Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform
9/2/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$320.00 ➝ $290.00	+105.69%
7/20/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C+) ➝ Hold (C)
7/20/2026	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bhavtosh Vajpayee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$145.00	+14.64%
6/11/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$225.00	+11.92%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$325.00	+61.66%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$320.00	+30.72%
5/7/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Neutral ➝ Buy	$255.00	+31.31%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Hold
3/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $210.00	+40.36%
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
3/9/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$375.00 ➝ $300.00	+102.48%
2/9/2026	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$160.00	+2.82%
1/12/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/26/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Bersey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$382.00	+85.95%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
Buffett's Final Warning: "The Dollar Is Going to Hell" (Ad) On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses. Watch how to protect yourself from what Dalio and Buffett see coming (free training).
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/25/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$175.00	-41.03%
9/15/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nay Soe Naing Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$202.00 ➝ $306.00	+1.24%
9/10/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$377.00	+14.80%
6/18/2025	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:00 PM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 22, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle's cloud business is experiencing explosive growth, with reported cloud growth of 121% and a remaining performance obligation backlog of approximately $664 billion, which suggests significant future revenue potential if the company executes successfully on these contracts.
The company recently reported strong financial results for the quarter ended September 10, 2026, beating analysts' consensus estimates with earnings per share of $1.92 compared to the expected $1.74, while also achieving revenue of $19.34 billion, which was up 29.6% on a year-over-year basis.
Oracle is currently trading at $149.12, which is significantly below its 52-week high of $325.00 and well below the consensus price target of $252.58, suggesting that the stock may be undervalued relative to its long-term growth prospects and analyst expectations.
The company has strengthened its position in the AI infrastructure market by ordering 50,000 AMD Instinct accelerators for Oracle Cloud Infrastructure, indicating a continued investment in expanding AI computing capacity and competing effectively against other major players in the sector.
Oracle has maintained its credibility in enterprise software by being named a leader in Gartner's HCM software report for the 11th consecutive year and in IDC's life-sciences R&D assessment, which supports the demand for its Fusion Cloud and industry-specific software offerings.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Investors are concerned about the company's capital-intensive growth strategy, which includes roughly $18 billion in data-center-related debt and negative free cash flow, raising the possibility that Oracle may need to issue new equity to fund its expansion, which could dilute existing shareholders.
Oracle recently cut more than 500 U.S. cloud-infrastructure jobs, including managers, engineers, developers, and data-center support staff, which may improve cost control but also raises concerns about operational pressure and the company's ability to execute on its ambitious AI expansion plans.
Some analysts have cautioned that Oracle's headline growth may not fully reflect the capital requirements and execution risks involved in its AI expansion, leading to a divided investor sentiment between viewing the stock as a potential major recovery or a value trap.
The company's debt-to-equity ratio is 1.89, which is relatively high and indicates that Oracle is leveraging a significant amount of debt to finance its operations and growth, which could be a risk if interest rates rise or if the company's cash flows do not meet expectations.
Oracle's stock has experienced significant volatility, with a 52-week range from $114.50 to $325.00, and the current price of $149.12 is near the lower end of this range, suggesting that the stock may be underperforming relative to its historical levels and that investors may be concerned about its future direction.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $252.58, with a high forecast of $400.00 and a low forecast of $145.00.

41 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There is currently 1 sell rating, 8 hold ratings, 30 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 74.87% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 1 downgrade by analysts.

Oracle has been rated by research analysts at Argus, Barclays, BMO Capital Markets, Cantor Fitzgerald, Citigroup, Citizens Jmp, CLSA, DA Davidson, Freedom Broker, Guggenheim, Jefferies Financial Group, KeyCorp, Morgan Stanley, Oppenheimer, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Oracle more than other "technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

MarketBeat monitors more than a dozen sources for Oracle analyst ratings, with the most recent rating issued on 9/14/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target